These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 23078734

  • 21. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R, Kirtane AJ, Torguson R, Cohen DJ, Ryan T, Räber L, Applegate R, Waxman S, Gordon P, Kaneshige K, Leon MB, DESERT Investigators.
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [Abstract] [Full Text] [Related]

  • 22. Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions.
    Assali A, Vaduganathan M, Vaknin-Assa H, Lev EI, Brosh D, Teplitsky I, Bental T, Battler A, Kornowski R.
    Am J Cardiol; 2012 Jun 01; 109(11):1563-8. PubMed ID: 22440117
    [Abstract] [Full Text] [Related]

  • 23. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.
    Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, Regar E.
    JACC Cardiovasc Interv; 2009 May 01; 2(5):445-52. PubMed ID: 19463469
    [Abstract] [Full Text] [Related]

  • 24. Predictors and implications of stent thrombosis in non-ST-segment elevation acute coronary syndromes: the ACUITY Trial.
    Palmerini T, Dangas G, Mehran R, Caixeta A, Généreux P, Fahy MP, Xu K, Cristea E, Lansky AJ, Stone GW.
    Circ Cardiovasc Interv; 2011 Dec 01; 4(6):577-84. PubMed ID: 22028471
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
    Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R, HORIZONS-AMI Trial Investigators.
    N Engl J Med; 2009 May 07; 360(19):1946-59. PubMed ID: 19420364
    [Abstract] [Full Text] [Related]

  • 30. Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation.
    De Luca G, Dirksen MT, Spaulding C, Kelbæk H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW, DESERT cooperation.
    Thromb Haemost; 2013 Oct 07; 110(4):826-33. PubMed ID: 23864101
    [Abstract] [Full Text] [Related]

  • 31. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
    Jensen LO, Maeng M, Thayssen P, Kaltoft A, Tilsted HH, Bøttcher M, Lassen JF, Hansen KN, Krusell LR, Rasmussen K, Pedersen KE, Pedersen L, Paaske Johnsen S, Sørensen HT, Thuesen L.
    Circ Cardiovasc Interv; 2008 Dec 07; 1(3):176-84. PubMed ID: 20031676
    [Abstract] [Full Text] [Related]

  • 32. Do patients with drug-eluting stent thrombosis have a similar prognosis to patients presenting with st-Elevation myocardial infarction of de novo lesions?
    Belle L, Mahmoudi M, Delhaye C, Ben-Dor I, Maluenda G, Gaglia MA, Torguson R, Satler LF, Pichard AD, Waksman R.
    J Interv Cardiol; 2011 Aug 07; 24(4):320-5. PubMed ID: 21535151
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trials.
    Hao PP, Chen YG, Wang XL, Zhang Y.
    Tex Heart Inst J; 2010 Aug 07; 37(5):516-24. PubMed ID: 20978561
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents.
    Leibundgut G, Nietlispach F, Pittl U, Brunner-La Rocca H, Kaiser CA, Pfisterer ME.
    Am Heart J; 2009 Aug 07; 158(2):271-6. PubMed ID: 19619705
    [Abstract] [Full Text] [Related]

  • 39. The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome.
    Beinart R, Abu Sham'a R, Segev A, Hod H, Guetta V, Shechter M, Boyko V, Behar S, Matetzky S.
    Am Heart J; 2010 Jan 07; 159(1):118-24. PubMed ID: 20102877
    [Abstract] [Full Text] [Related]

  • 40. Incidence and predictors of very late (>or=4 years) major cardiac adverse events in the DESIRE (Drug-Eluting Stents in the Real World)-Late registry.
    Costa JR, Sousa A, Moreira AC, Costa RA, Cano M, Maldonado G, Campos C, Carballo M, Pavanello R, Sousa JE.
    JACC Cardiovasc Interv; 2010 Jan 07; 3(1):12-8. PubMed ID: 20129562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.